Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Streamed live on Jun 28, 2013
This session begins Friday, June 28 from 5 - 6:15 p.m. The session will explore how the Argus II retinal prosthesis, the first device of its kind to be approved by the U.S. Food and Drug Administration, may benefit people with late-stage retinitis pigmentosa. Expert panelists will discuss how the device works and what is involved from a patient's perspective.
Dr. Jacque Duncan Dr. Duane Geruschat Dr. James Handa Dr. Brian Mech Kathy B. - Patient